Showing results (161-170 of 527) with videos related to

Sort By:
Pageof 53
Nature Medicine|January 30, 2025
Toward a biological definition of neuronal and glial synucleinopathiesClaudio Soto, Brit Mollenhauer, Oskar Hansson, et al.
Movement Disorders Clinical Practice|December 4, 2024
Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain StimulationPawel Jarski, Turab Gasimov, Cristina Dragaescu, et al.
Sleep Medicine|August 17, 2020
A data-driven system to identify REM sleep behavior disorder and to predict its progression from the prodromal stage in Parkinson's diseaseMatteo Cesari, Julie A E Christensen, Maria-Lucia Muntean, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 15, 2016
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementiaCarla Abdelnour, Inger van Steenoven, Elisabet Londos, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
A Clinically Applicable Interactive Micro and Macro-Sleep Staging Algorithm for Elderly and Patients with NeurodegenerationMatteo Cesari, Julie A E Christensen, Friederike Sixel-Doring, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2018
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2025
Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein SeedsSandrina Weber, Carly M Farris, Yihua Ma, et al.
International Journal of Molecular Sciences|December 11, 2025
Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's DiseaseMary Xylaki, Avika Chopra, Yevheniia Kyriachenko, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2011
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCIIrene Litvan, Dag Aarsland, Charles H Adler, et al.
Plos One|October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's diseaseMichael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Pageof 53